NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading PepsiCo, Peloton, and Dutch Bros are on UBS’ list of top consumer stocks.